RegenLab Cellular Matrix A-CP-HA, imported from Switzerland, is a homogeneous injection of hyaluronic acid and high-concentration autologous platelet plasma approved by the Ministry of Health and Welfare. It is a third-class medical device certified by CE and TFDA.
1. Vacuum sterile system A-CP-HA blood collection tube with independent plastic packaging
2. The only autologous high-concentration platelet plasma plus hyaluronic acid homogenized joint injection on the market
3. Swiss RegenLab original imported, CE and TFDA certified third-level medical equipment
4. Only a small amount of 6 cc blood can be prepared
This product is composed of sterile blood collection tubes and is designed to prepare a mixture of platelet concentrate (PRP) and hyaluronic acid (HA). 3ml of platelet concentrate (PRP) corresponds to 2ml of hyaluronic acid (HA). Each box includes 3 individually plastic-packed A-CP-HA blood collection tubes. For the preparation of intra-articular injections for the treatment of knee pain, such as grade I to III knee osteoarthritis. It is recommended to inject one dose at a time, for a total of three injections, with an interval of two weeks between each injection. For patients who had been treated with hyaluronic acid and were unsatisfied with the clinical effect, RegenLab was used for product research. As a result, as high as 87.3% of patients had significantly improved joint pain and mobility.